Recombinant fusion protein-extracellular portion of CD95 fused to the Fc part of human IgG1

[email protected]
Recombinant fusion protein-extracellular portion of CD95 fused to the Fc part of human IgG1
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2009-10-13 00:00:00
Sponsor Apogenix GmbH;Im Meuenheimer Feld 584;
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM